In addition, administrations of a ferroptosis inhibitor, Lip-1, not only prevented the emergence of psoriasis, but also successfully treated an established psoriasiform dermatitis and systemic inflammation of K14/Gpx4 mice receiving TMX (Figure 6, E–H). This evidence concerns the gene KRT14 and psoriasis.